Key result
Transseptal SAPIEN M3 TMVR proves feasible under deep sedation with spontaneous ventilation without intubation.
Why the study?
Published experience of transseptal transcatheter mitral valve replacement with the SAPIEN M3 system has been under general anesthesia, and implantation under deep sedation with spontaneous ventilation without tracheal intubation had yet to be described.
Is transseptal transcatheter mitral valve replacement with the SAPIEN M3 system feasible under deep sedation with spontaneous ventilation without tracheal intubation?
Case Report (n=1)
Is transseptal transcatheter mitral valve replacement with the SAPIEN M3 system feasible under deep sedation with spontaneous ventilation without tracheal intubation?
This case report demonstrates the feasibility of performing transseptal SAPIEN M3 transcatheter mitral valve replacement under deep sedation with spontaneous ventilation, potentially offering an alternative for patients at high risk for general anesthesia.
Answers are grounded in this paper and cite their sources.
May warrant consideration of deep sedation for select high-risk TMVR cases; leaves open need for prospective validation.
OBJECTIVE: The SAPIEN M3 is a transseptal system for transcatheter mitral valve replacement, and published experience of implantation has been under general anesthesia. We describe its implantation under deep sedation with spontaneous ventilation, without tracheal intubation. KEY STEPS: Confirm adequate midesophageal and transgastric image quality and favorable computed tomographic anatomy. Place the patient under deep sedation with dexmedetomidine, propofol, and fentanyl, under arterial pressure, bispectral index, and capnographic monitoring, with predefined conversion criteria. Obtain transseptal access, position the dock under prolonged transgastric imaging, and deploy the valve under rapid pacing. Monitor ventilation and oxygenation with serial arterial blood gases. POTENTIAL PITFALLS: Aspiration with an unprotected airway during prolonged probe manipulation, and loss of the stable conditions needed throughout a long procedure, require meticulous anesthetic monitoring and immediate capability for conversion. TAKE-HOME MESSAGES: This case demonstrates that SAPIEN M3 implantation is feasible under deep sedation with spontaneous ventilation. In selected patients at increased risk from general anesthesia, deep sedation may extend this therapy, a possibility that larger series should now test.
No takes yet. Share an insight, caveat, or question.
Lobo et al. (2026) conducted a case report in Mitral valve disease requiring transcatheter mitral valve replacement (n=1). Transseptal transcatheter mitral valve replacement (SAPIEN M3) under deep sedation with spontaneous ventilation (dexmedetomidine, propofol, and fentanyl) was evaluated on Feasibility of SAPIEN M3 implantation under deep sedation with spontaneous ventilation. SAPIEN M3 transseptal transcatheter mitral valve replacement was feasible under deep sedation with spontaneous ventilation without tracheal intubation in 1 case.
Synapse has enriched 10 related papers. Consider them for comparative context: